ArticleJournal of cardiothoracic surgery2024
The predictive value of monocyte count to high-density lipoprotein cholesterol ratio combined with left atrial diameter for post-radiofrequency ablation recurrence of paroxysmal atrial fibrillation in patients.
Article in Journal of cardiothoracic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Circulating lipid profiles and atrial fibrillation: from incident risk to post-ablation recurrence.Frontiers in cardiovascular medicine · 2026Review
- Predictive value of the monocyte-to-high-density lipoprotein cholesterol ratio in atrial fibrillation: a meta-analysis.Frontiers in cardiovascular medicine · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundParoxysmal atrial fibrillation (PAF) usually recurs after radiofrequency ablation (RFA). This study probed the predictive value of monocyte count to high-density lipoprotein cholesterol (HDL-C) ratio (MHR) with left atrial diameter (LAD) for post-RFA recurrence in PFA patients.
methodsTotally 210 RFA-treated PAF patients were selected and assigned into Recurrence and Non-Recurrence groups, with clinical baseline data recorded. Preoperative HDL-C, hypersensitive C-reactive protein, interleukin-6, tumor necrosis factor alpha, brain natriuretic peptide, low-density lipoprotein cholesterol, total cholesterol, and total cholesterol were determined. Monocyte count and MHR were examined. The effects of preoperative MHR and LAD on post-RFA PAF recurrence was analyzed by COX regression analysis. Patients were arranged into high and low MHR and high and low LAD groups. The recurrence of PAF patients with different preoperative MHR and LAD within 12 month was analyzed by Kaplan-Meier (KM) analysis. The predictive value of preoperative MHR, LAD, and their combination for post-RFA recurrence in PAF patients was analyzed.
resultsMHR and LAD were independent risk factors for post-RFA recurrence in PAF patients. KM curve shift left in the high MHR and LAD groups versus the low MHR and LAD groups. MHR and LAD could help predict post-RFA recurrence in PAF patients, and the combined predictive value of MHR and LAD was greater than that of either factor alone.
conclusionMHR and LAD are independent risk factors for post-RFA PAF recurrence, and can help predict post-RFA recurrence in PAF patients, with their combined predictive value higher than that of each factor individually.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.